- Home
- ZURA vs NWAX Comparison
ZURA vs NWAX Comparison
Compare ZURA & NWAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZURA | NWAX |
|---|---|---|
| Founded | 2022 | 2025 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 595.9M | 502.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ZURA | NWAX |
|---|---|---|
| Price | $5.99 | $10.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $11.78 | N/A |
| AVG Volume (30 Days) | ★ 482.0K | 75.8K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.99 | $10.00 |
| 52 Week High | $7.25 | $10.25 |
Technical Indicators
Market Signals| Indicator | ZURA | NWAX |
|---|---|---|
| Relative Strength Index (RSI) | 42.39 | 46.21 |
| Support Level | $5.62 | $10.00 |
| Resistance Level | $6.99 | $10.10 |
| Average True Range (ATR) | 0.50 | 0.03 |
| MACD | -0.12 | -0.00 |
| Stochastic Oscillator | 5.19 | 50.00 |
Price Performance
Historical ComparisonAbout ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About NWAX New America Acquisition I Corp. Class A Common Stock
New America Acquisition I Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which it refers to throughout this prospectus as its initial Business Combination.